NSC |
Compound |
Enrichment |
Correlation |
NSC 715778 |
Null |
0.0228801759885691 |
0.41717724 |
NSC 728038 |
2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline |
0.0228801759885691 |
0.23259584 |
NSC 733467 |
Null |
0.0228801759885691 |
0.21450361 |
NSC 735030 |
Null |
0.0228801759885691 |
0.32413384 |
NSC 735373 |
Bis{(5,6-dihydro-5,11-diketo-2,3-dimethoxy-11H-indeno[1,2-c] isoquinoline)-6-propylamino}propane Bis(trifluoroacetate) |
0.0228801759885691 |
0.3049253 |
NSC 740 |
Methotrexate |
0.0228801759885691 |
0.36681825 |
NSC 763059 |
Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride |
0.0228801759885691 |
0.082538506 |
NSC 618759 |
4-Penten-3-one, 5,5'-(1,4-phenylenbis)bis[2,2-dimethyl- 1-piperidino-, (E,E)-, dihydrobromide |
0.0238174255956144 |
0.34643962 |
NSC 621727 |
Null |
0.0238174255956144 |
0.51450032 |
NSC 626879 |
Cyclopentanone, 2-[(dimethylamino)methyl]-5-heptylidene-, hydrochloride |
0.0238174255956144 |
0.41074182 |